Publications

Export 79 results:
Filters: Author is M-A Roy  [Clear All Filters]
2020
M. - A. Nolin, Demers, M. - F., Rauzier, C., Bouchard, R. - H., Cadrin, C., Després, J. - P., M-A Roy, Alméras, N., and Picard, F., Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics., World J Biol Psychiatry, pp. 1-8, 2020.
M-A Roy, The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017., Can J Psychiatry, vol. 65, no. 7, pp. 510-511, 2020.
E. Stip, Grignon, S., M-A Roy, Bloom, D., Osman, O., Amiri, L., Aziz, K. Abdul, Javaid, S. Fahad, and Arnone, D., From QAAPAPLE 1 to QAAPAPLE 2: How do we move from one algorithm to another one with Long acting antipsychotics (LAIs)., Expert Rev Neurother, 2020.
P. Gagnon, Gaudreau, J. - D., M-A Roy, and Moreau, J. Le Moignan, Letter to the Editor: Correction About the Nursing Delirium Screening Scale in Response to: "A Study of the Psychometric Properties of the "Stanford Proxy Test for Delirium" (S-PTD): A New Screening Tool for the Detection of Delirium"., Psychosomatics, 2020.
Y. C. Chagnon, Maziade, M., Paccalet, T., Croteau, J., Fournier, A., M-A Roy, and Bureau, A., A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds., Eur J Hum Genet, vol. 28, no. 4, pp. 499-507, 2020.
W. Pothier, M-A Roy, Corbière, M., Thibaudeau, É., Achim, A., Wykes, T., Reeder, C., Chagnon, Y., and Cellard, C., Personalized cognitive remediation therapy to facilitate return to work or to school in recent-onset psychosis., Neurocase, vol. 26, no. 6, pp. 340-352, 2020.
O. Corbeil, Corbeil, S., Giroux, I., Jacques, C., Dorval, M., Demers, M. - F., and M-A Roy, Problem Gambling Associated With Aripiprazole in First-Episode Psychosis Patients: A Series of 6 Case Reports., J Clin Psychopharmacol, vol. 40, no. 2, pp. 191-194, 2020.
V. Ferraro, Lafrenière, S., Demers, M. - F., M-A Roy, and Abdel-Baki, A., "Real world" clinical effectiveness of paliperidone palmitate 3-monthly injectable in early psychosis patients., Psychopharmacology (Berl), 2020.

Funding / Support / Partners

logo FRQ-S logo ctrn logo fci logo cihr irsc logo nserc logo MESISentinelle nord